Adverse effects and adherence to treatment of rifampicine 4 months vs isoniazid 6 months for latent tuberculosis: a retrospective analysis.

Swiss medical weekly

Volumn 141, Issue , 2011, Pages

  Fresard I ^a   Bridevaux, P P ^b   Rochat, T ^b   Janssens, J P ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; HUMAN; LATENT TUBERCULOSIS; MALE; METABOLISM; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; TOXIC HEPATITIS;

ADULT; ALANINE TRANSAMINASE; ANTITUBERCULAR AGENTS; ASPARTATE AMINOTRANSFERASES; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; ISONIAZID; LATENT TUBERCULOSIS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; RIFAMPIN; YOUNG ADULT;

EID: 84855176616     PISSN: None     EISSN: 14243997     Source Type: Journal    
DOI: None     Document Type: Article

References (0)